From generics to emerging technologies and distribution partnerships, innovative routes to market are expanding reach and reshaping the competitive landscape. Leaders share how new models are lowering barriers to entry, driving scale, accelerating time to market, and creating sustainable value across the ecosystem.
Transboundary animal diseases (TADs) such as avian influenza, bluetongue virus, and foot-and-mouth disease pose serious risks to animal health, livestock production, and public health. Past outbreaks have exposed gaps in disease awareness and preparedness, with farmers often bearing the greatest impact. Effective prevention, through international collaboration, biosecurity, vaccination, and surveillance, requires coordinated action to stop the spread and support eradication efforts.
Albert Picado is a Veterinary Epidemiologist with over 20 years of experience in designing and conducting epidemiological studies, as well as in the development, evaluation, and implementation of control tools for infectious diseases affecting both animals and humans. Currently serving as Principal Scientist within the Viral Diseases Research (VDR) team at Boehringer Ingelheim in Lyon (France), Albert provides strategic epidemiological support for the development of vaccines targeting priority infectious diseases. His work includes a strong focus on Transboundary Animal Diseases (TADs), contributing to global efforts to improve disease prevention and control through innovative vaccine solutions.
Our panellists will discuss where data and AI are going to have the greatest impact on advancing health outcomes, the delivery of care and R&D.
